Shopping Cart
- Remove All
 Your shopping cart is currently empty Your shopping cart is currently empty
Aminomalonic acid is an amino endogenous metabolite that acts as a potent inhibitor of L-asparagine synthetase from Leukemia 5178Y/AR and mouse pancreas in vitro (Leukemia 5178Y/AR: Ki= 0.0023 M, mouse pancreas: Ki= 0.0015 M). It has the potential to be used as a biomarker to distinguish between different stages of melanoma metastasis.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $48 | In Stock | |
| 5 mg | $143 | In Stock | |
| 10 mg | $228 | In Stock | |
| 25 mg | $389 | In Stock | |
| 50 mg | $572 | In Stock | |
| 100 mg | $813 | In Stock | 
| Description | Aminomalonic acid is an amino endogenous metabolite that acts as a potent inhibitor of L-asparagine synthetase from Leukemia 5178Y/AR and mouse pancreas in vitro (Leukemia 5178Y/AR: Ki= 0.0023 M, mouse pancreas: Ki= 0.0015 M). It has the potential to be used as a biomarker to distinguish between different stages of melanoma metastasis. | 
| In vitro | Fractions of TMYXP were prepared by high performance liquid preparation technology. The cardioprotective effects of prepared fractions were tested on H2O2 oxidation-damaged H9c2 myocardiocytes. The active components were analyzed by high performance liquid chromatography (HPLC) coupled with high resolution mass spectrometry. The possible active compounds were putatively identified by comparison of their MS ions and molecular weight with literatures. Ten TMYXP components presented significant myocardial protective activities, 5 of which were investigated and presented good dose-effect relationships. Their median effective concentrations (EC50) were respectively 11.66, 17.44, 13.10, 7.332, 15.15 μg/mL. Totally, 11 potential active compounds were analyzed and identified, including Glycyrrhizic acid, Glycycoumarin, Licoisoflavone, Ophiopogonin D', Licoricon, Gancaonin L, Neoglycyrol, Emodin, Angeloylgomisin H, Angeloylgomisin Q and Glyasperin A. | 
| Molecular Weight | 366.36 | 
| Formula | C21H18O6 | 
| Cas No. | 23013-84-5 | 
| Smiles | COc1c(CC=C(C)C)c(O)cc2oc(=O)c3c4ccc(O)cc4oc3c12 | 
| Relative Density. | 1.371 g/cm3 (Predicted) | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 3.66 mg/mL (10 mM), Sonication is recommended.   | ||||||||||||||||||||
| Solution Preparation Table | |||||||||||||||||||||
| DMSO 
 | |||||||||||||||||||||
 For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .  A total of 10 animals were administered, and the formula you used is 5%
 A total of 10 animals were administered, and the formula you used is 5%  DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first. main solution, add 300 μLPEG300
 main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O
 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
 mix well and clarify
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.